← SynDRA
PAMIPARIB
SynDRA canonical compound SYN0039293 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | PARP1 | PARP2 |
|---|
| Mechanism of action | PARP inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PARP1 INHIBITOR
- Poly [ADP-ribose] polymerase-1 inhibitor
- PARP2 INHIBITOR
- Poly [ADP-ribose] polymerase 2 inhibitor
- PARP inhibitor
Drug classes
- Poly(ADP-ribose) Polymerase Inhibitors
ATC classes
- L01X · OTHER ANTINEOPLASTIC AGENTS
Cross-references
Synonyms
- BGB-290
- pamiparibum
- RefChem:858446
- PARP Inhibitor BGB-290
- Pamiparib [INN]
- Pamiparib [USAN]
- BGB290
- MFCD30489383
- Pamiparib (BGB-290)
- Partruvix
- Pamiparib?
- Pamiparib free base
- Pamiparib (Standard)
- Pamiparib (USAN/INN)
- Pamiparib [USAN:INN]
- PAMIPARIB [WHO-DD]
- orb1302131
- SCHEMBL15084918
- UNII-8375F9S90C
- GTPL12345
- DENYZIUJOTUUNY-MRXNPFEDSA-N
- EX-A2869
- BDBM50639171
- NSC804253
- s8592
- AKOS030527932
- HY-104044R
- NSC-804253
- NCGC00510231-02
- AC-36901
- BP180190
- MS-24286
- SY293390
- compound 139 [PMID: 33264017]
- DB-179450
- HY-104044
- CS-0027388
- D11426
- D87155
Look up PAMIPARIB in the interactive SynDRA portal →